Project Grant R21EB036886
- This $360,320 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop and test the first continuous electrochemical sensors for monitoring large protein and peptide analytes, such as insulin and cardiac markers. The project, titled "Aptamer Tagging with Redox Quenchers: A Critical Breakthrough in the Sensitivity of...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $446,199 Cooperative Agreement under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Winston-Salem State University (WSSU) and partner institutions. The project aims to develop a multimodal sensor platform using advanced nanomaterials and detection technologies to enable simultaneous, rapid, and accurate measurement of multiple hormone biomarkers...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $359,995 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Clemson University. The funding supports the development and validation of a novel X-ray visualized immunosensor (X-VIS) that can be attached to implanted medical devices to detect and monitor local infection biomarkers. The project aims to fabricate a...
- This National Science Foundation Project Grant of $395,312 will fund the development of shape-encoded electrokinetic particles for multiplexed biosensing through June 2027. Under the NSF Engineering Directorate's CFDA 47.041 program, the University of Colorado Boulder will work to advance biosensing technologies that can detect heterogeneous biomarkers from blood in a single assay. Specifically, the university will study how biomarker size, charge density, and concentration influence the induced...
- The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
- This Project Grant award, valued at $595,353 and issued on February 1, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), supports the development of ultrasensitive ion-selective optodes for self-testing of blood electrolytes. The goal is to create a novel colorimetric sensor capable of detecting electrolyte levels in just a few microliters of whole blood, revolutionizing the self-monitoring of chronic conditions like hypoparathyroidism and congestive heart failure....
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop living biosensors to detect and analyze DNA at the single-base level without requiring sample purification or specialized equipment. The $565,614 award will produce a hybrid living biosensor/lateral flow assay that can rapidly detect target DNA sequences,...
- This federal Project Grant award of $349,566 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology for high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The key products and services delivered through this award include: Integration of innovative technologies...
- This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) award of $1,200,000 provides funding to the University of California, Berkeley from October 1, 2024 to September 30, 2028 to develop innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this project grant are to: (1) develop molecular engineering techniques using DNA origami...
- This $399,935 National Science Foundation (NSF) Project Grant Award under the Computer and Information Science and Engineering program (CFDA 47.070) aims to develop a portable and cost-effective biomedical diagnostic system in the form of an integrated lab-on-a-chip platform produced using additive manufacturing techniques. The key products and services to be delivered include: Advancing 3D manufacturing techniques, particularly in electrode printing, to enhance fabrication precision and...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $413,067 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Colorado State University to develop a new class of electrochemical biosensors that use engineered binding proteins. The goal is to simplify fabrication and improve performance of electrochemical sensors, which have potential for inexpensive, sensitive, and quantitative diagnostic assays. The project period is 9/1/2025 to 8/31/2027 and aims to address a major obstacle in achieving reproducible electrode modification strategies for electrochemical immunosensors that can be adapted for large-scale manufacturing while maintaining sensitivity and specificity.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $413.1k | 8/5/25 |